Next Investors

Our biotech Investment Neurotech International (ASX: NTI) released gene analysis on its cannabinoid based biopharmaceutical NTI164. The upshot - NTI now has research which shows NT164 works on a cellular level, altering proteins and genes that are associated with neuroinflammation. This gene analysis is a bit like uncovering the reason NT164 works. We think it could imply that a larger range of disorders linked to neuroinflammation may be treated too. Read more here: https://bit.ly/4gkuzMf Disc: 7,145,000 NTI Shares Held.

Our 2024 Tech Pick of the Year AML3D (ASX:AL3) just signed a Manufacturing License Agreement with a US Navy intermediary. This will increase the library of 3D printed parts that the US Navy can order from AL3. Read more about it here: https://bit.ly/4gjg7Eh Disc: 6,777,530 AL3 Shares Held.

Earlier this week, reports emerged that oil and gas supermajor Shell was flaring gas in the Taroom Trough in Queensland. Our Investment Elixir Energy (ASX:EXR) has acreage next door to Shell in the Taroom Trough. Read more here: https://bit.ly/3AV4cfw Disc: 3,444,000 EXR Shares & 1,555,357 EXR Options Held.

Today we are announcing our newest Investment. It’s an ASX healthcare technology stock just a few weeks from a major share price catalyst. After months of due diligence, we have now found another ASX tech stock that fits our investment criteria, and we have decided to Invest. Here’s why: https://bit.ly/3zc9dQr Disc: 3,470,000 EIQ Shares Held by Company & 140,000 EIQ shares Held by Company’s Staff.

EMD is currently delivering psychedelic assisted therapies, in particular MDMA-assisted therapy for Post Traumatic Stress Disorder (PTSD). Yesterday, the company gave investors a look at interim results for its first 8 patients. Read more here: https://bit.ly/3Mw86OE Disc: 5,866,667 EMD Shares & 2,500,000 EMD Options Held.

Two offtakes in two weeks. And possibly “Strategic Project Status” at the end of the year... Momentum is now building for our EU based critical mineral Investment Euro Manganese (ASX:EMN). Read more here: https://bit.ly/4e0VFpQ Disc: 1,223,000 EMN Shares Held.

Our micro-cap exploration Investment, TechGen Metals (ASX:TG1) just released news of rock chips with grades as high as 7.05% antimony. Read about it here: https://bit.ly/3yJH7vT Disc: 5,810,000 TG1 Shares & 1,133,929 TG1 Options Held.

The ASX small cap market lives on hopes and speculation - and after a rough couple of years, this week, antimony and antimony stocks delivered some. Read all about our commentary right here: https://bit.ly/4cDVXSj

SS1 is currently running a 7,500m drill program to grow the size and upgrade the classification of its 292,000,000 ounce silver equivalent JORC resource in Nevada, USA. Three weeks ago SS1 announced onsite XRF drill results with silver grades of up to 296 g/t silver. ...and a 1,466 ppm (0.146%) sniff of antimony. Read all about it here: https://bit.ly/3SSPgVx Disc: 3,810,000 SS1 Shares Held.

IIQ said today that it had further validated its NEURO-NET technology - greatly increasing the potential for earlier detection of the onset for Parkinson's disease Read more about this advancement below: https://bit.ly/3MajUGf Disc: 1,150,000 IIQ Shares & 525,000 IIQ Options Held.